Christine Ring

Christine Ring, listed as board member, appears in our data through filings on Nurix Therapeutics, Inc. shares, published by SEC (Form 4). We count 64 filings; the first trade dates from 10 May 2021 and the latest from 2 October 2026.

The open-market record consists of 9 sales worth €1.1M, with no purchase. The amount is not disclosed for 1 filing. The rest of the record consists of 55 option exercises. 2026 to date brings no purchases and 9 sales.

Most recently, on 2 October 2026, the filings show an option exercise worth €45k in Nurix Therapeutics, Inc. The median gap between a trade and its publication by SEC (Form 4) is 2 days. Section 16 rules allow two business days to file each Form 4. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.